MCA logo

PUBLIC PORTAL

MCA logo

MEDICALLY REVIEWED

Ixekizumab (Taltz) for the Treatment of Plaque Psoriasis

ixekizumab (Taltz) plaque psoriasis

Psoriasis is a common skin disease with a global prevalence of 2-3%, and affects over 40,000 people in Singapore. The chronic inflammatory condition with . . .

Sign Up or Log In as a healthcare professional to read the full article.

Kaye

Kaye

Kaye obtained her Masters of Pharmacy degree from the University College London and has spent the better part of her career as a clinical pharmacist in a tertiary care hospital. Her professional interests are centred on HEOR and HTA work, in hopes of ultimately influencing cost-effective decisions for patient care.

Share via

Also worth reading

People also read:

World Sleep Day 2023
World Sleep Day 2023

The purpose of World Sleep Day is to raise awareness of the importance of sleep and the impact that sleep has on our health and well-being

Read More »
March 17, 2023

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

About Us

Advertise

Contact Us

My Account

Privacy Policy

FOLLOW MCA

Facebook-f Tiktok Youtube Instagram Linkedin-in Telegram-plane

ACCREDITATIONS

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

About Us

Advertise

Contact Us

Privacy Policy

FOLLOW MCA

Facebook-f Tiktok Youtube Instagram Linkedin-in Telegram-plane

ACCREDITATIONS

Copyright © Medical Channel Asia 2022. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.